Alopecia areata, also known as spot baldness, is an autoimmune disease in which hair is lost from some or all areas of the body, usually from the scalp, due to the body's failure to recognize its own body cells and subsequent destruction of its own tissue. Alopecia Pipeline Market Research Report provides the latest projects and drug profiles with key companies.
Introduction:
Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=911451 .
The Pharmaceutical and Healthcare latest pipeline guide Alopecia Pipeline Review H1 2017, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Key Company Profiles:
Aclaris Therapeutics Inc, Allergan Plc, Almirall SA. AndroScience Corp, Berg LLC, BiologicsMD Inc, BirchBioMed Inc, Bristol-Myers Squibb Company, Cassiopea SpA, Concert Pharmaceuticals Inc, Dong-A Socio Holdings Co Ltd, Follicum AB, Handok Inc, Histogen Inc, Hyundai Pharmaceutical Co Ltd, Incyte Corp, Kuhnil Pharmaceutical Co Ltd, Lee's Pharmaceutical, Holdings Ltd, LEO Pharma A/S, Medivir AB, NovaLead Pharma Pvt Ltd, Novartis AG, Panacea Biotec Ltd, Pfizer Inc, Quark Pharmaceuticals Inc, RiverTown Therapeutics Inc, RXi Pharmaceuticals Corp, Samumed LLC, SWITCH Biotech LLC, Taisho Pharmaceutical Holdings Co Ltd, Tigo GmbH, viDA Therapeutics Inc.
Alopecia - Drug Profiles:
(cyclosporine A + minoxidil + RT-175) - Drug Profile, abatacept - Drug Profile, AI-001 – Drug Profile, ASCJ-9 - Drug Profile, ATI-50001 - Drug Profile, ATI-50002 - Drug Profile, ATI-50003 - Drug Profile, bimatoprost - Drug Profile, BMD-1141 - Drug Profile, BMD-1341 - Drug Profile, BMD-2341 - Drug Profile, BQ-A - Drug Profile, BRM-421 - Drug Profile, calcitriol - Drug Profile, CB-0301 - Drug Profile, CTP-543 - Drug Profile, DHL-HisZnNa - Drug Profile, finasteride - Drug Profile, finasteride - Drug Profile, FOL-005 - Drug Profile, HGEN-001 - Drug Profile, HL-5945 - Drug Profile, HTB-005 - Drug Profile, interferon beta-1b - Drug Profile, KI-1104 - Drug Profile, KI-1105 - Drug Profile, LEO-124249 - Drug Profile, minoxidil - Drug Profile, NLP-602 - Drug Profile, OLX-104 - Drug Profile, PF-06651600 - Drug Profile, PF-06700841 - Drug Profile, QPAL-1 - Drug Profile, QPAL-2 - Drug Profile.

Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=911451
Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology).
The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)
Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=911451 .
Table of Contents:
Alopecia - Overview
Alopecia - Therapeutics Development
Alopecia Pipeline Overview
Alopecia Pipeline by Companies
Alopecia - Therapeutics Assessment
Alopecia - Companies Involved in Therapeutics Development
Alopecia - Drug Profiles
Alopecia - Dormant Projects
Alopecia - Product Development Milestones and more…

List of Tables.
Number of Products under Development for Alopecia , H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Alopecia - Pipeline by Pfizer Inc, H1 2017
Alopecia - Pipeline by Handok Inc, H1 2017
Alopecia - Pipeline by LEO Pharma A/S, H1 2017
Alopecia - Dormant Projects, H1 2017 and more…

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with your contact details.